REGN
Regeneron Pharmaceuticals Inc
NASDAQ: REGN · HEALTHCARE · BIOTECHNOLOGY
$707.06
+3.02% today
Updated 2026-04-30
Market cap
$74.13B
P/E ratio
17.27
P/S ratio
4.97x
EPS (TTM)
$40.94
Dividend yield
0.52%
52W range
$475 – $820
Volume
0.7M
Regeneron Pharmaceuticals Inc (REGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $23.07M | $27.37M | $-89.09M | $-72.23M | $96.34M | $-141.68M | $-74.61M | $588.60M | $752.43M | $1.33B | $1.49B | $1.31B | $2.20B | $2.43B | $2.62B | $7.08B | $5.01B | $4.59B | $4.42B | $4.98B |
| Capital expenditures | $2.81M | $18.45M | $34.86M | $97.32M | $99.69M | $57.22M | $49.34M | $156.32M | $333.01M | $677.93M | $511.90M | $272.60M | $383.10M | $429.60M | $614.60M | $551.90M | $590.10M | $926.40M | $755.90M | $898.40M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $28.07M | $32.52M | $31.26M | $39.90M | $56.09M | $94.16M | $198.40M | $307.24M | $459.05M | $559.88M | $507.28M | $427.40M | $464.30M | $432.00M | $601.70M | $725.00M | $885.00M | $982.80M | $993.70M |
| Free cash flow | $20.26M | $8.93M | $-123.94M | $-169.55M | $-3.35M | $-198.90M | $-123.95M | $432.27M | $419.43M | $652.85M | $974.00M | $1.03B | $1.81B | $2.00B | $2.00B | $6.53B | $4.42B | $3.67B | $3.66B | $4.08B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $294.55M | $547.47M | $500.18M | $358.69M | — | — | — | — | — | $0.00 | $0.00 | $370.30M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-94.50M | $371.04M | $-253.33M | $305.33M | $113.11M | $160.38M | $-273.90M | $277.53M | $655.00M | $150.10M | $577.00M | $690.80M | $221.30M | — | — | — |